瑞普利蒙生物 REPL
$21.62 +$1.60 (+7.99%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $21.61 -0.05%
开盘$20.20
昨收$20.02
当日区间$20.20 – $21.91
成交量2.98M
市值$2.05B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数6
平均目标价$22.33+3.3% 较现价
- 买入 100%
最低 $14.00现价 $21.62均值 $22.33最高 $31.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$9.00至$31.00，平均为$18.95。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 29 Oct 2026 | Wedbush | BUY | $19.00 |
| 29 Oct 2026 | Leerink Partners | BUY | $31.00 |
| 28 Oct 2026 | Jefferies | BUY | $29.00 |
| 28 Oct 2026 | BMO Capital | BUY | $20.00 |
| 10 Sep 2026 | BMO Capital | BUY | $20.00 |
| 26 Aug 2026 | J.P. Morgan | BUY | $21.00 |
| 17 Aug 2026 | Wedbush | BUY | $19.00 |
| 17 Aug 2026 | Jefferies | BUY | $24.00 |
| 17 Aug 2026 | BMO Capital | BUY | $20.00 |
| 10 Aug 2026 | J.P. Morgan | BUY | $20.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $14.00 |
| 7 Aug 2026 | Wedbush | BUY | $19.00 |
| 7 Aug 2026 | BMO Capital | BUY | $20.00 |
| 3 Aug 2026 | Leerink Partners | BUY | $17.00 |
| 31 Jul 2026 | Cantor Fitzgerald | BUY | – |
| 31 Jul 2026 | Piper Sandler | BUY | $14.00 |
| 31 Jul 2026 | Wedbush | HOLD | $12.00 |
| 31 Jul 2026 | BMO Capital | BUY | $16.00 |
| 28 Jul 2026 | Wedbush | HOLD | $9.00 |
| 28 Jul 2026 | BMO Capital | BUY | $16.00 |
暂无评论——快来第一个聊聊 REPL。
登录后参与讨论。